We report that human T cells persistently infected with primate foamy virus type 1 (PFV-1) display an increased capacity to bind human immunodeficiency virus type 1 (HIV-1), resulting in increased cell permissiveness to HIV-1 infection and enhanced cell-to-cell virus transmission. This phenomenon is independent of HIV-1 receptor, CD4, and it is not related to PFV-1 Bet protein expression. Increased virus attachment is specifically inhibited by heparin, indicating that it should be mediated by interactions with heparan sulfate glycosaminoglycans expressed on the target cells. Given that both viruses infect similar animal species, the issue of whether coinfection with primate foamy viruses interferes with the natural course of lentivirus infections in nonhuman primates should be considered.
Virus replication can be modulated by the presence of either homologous defective viral genomes or viruses of distinct classes capable of interfering with particular stages of the virus cycle in dually infected organisms. It is established that coinfection with other retroviruses (human T-cell leukemia virus types 1 and 2) (31), human herpesviruses (human herpesvirus type 6 [HHV-6], HHV-7, and HHV-8) (4, 7, 9, 12, 32) , or nonpathogenic flavivirus GB virus (30) influences progression of human immunodeficiency virus type 1 (HIV-1) disease. Foamy viruses (FVs) are innocuous complex retroviruses that establish lifelong persistent infection in their hosts without inducing disease (13, 15, 17, 19) . Persistence of primate foamy virus type 1 (PFV-1), the prototype of FVs, is associated with accumulation of a defective homologous provirus, PFV⌬Tas, generated by alternative splicing of the wild-type genomic RNA, deleting a 301-bp intron in the viral transactivator tas gene (18, 26, 33) , which negatively interferes with replication of its parental counterpart by production of the regulatory Bet protein (18, 26, 33) . Interestingly, FV distribution among mammalian species mirrors that of lentiviruses (15, 17) , and although FVs display broad cell tropism, both infect T cells and macrophages (29) .
Looking for possible interference with lentivirus replication, we investigated the impact of acute PFV-1 infection on HIV-1 replication by exposing human H9 T cells (22) to X4 HIV-1 LAI plus or minus PFV-1. No significant effect of PFV-1 infection on HIV-1 replication was noted as monitored by sequential p24 (Coulter R HIV-1 p24 antigen assay) and HIV-1 DNA quantification. However, due to massive cell lysis, the experiment could not be prolonged beyond 8 days postinfection (p.i.) (data not shown). We next examined this point in a system that harbors the PFV genome without cell lysis. Hence, H9 cells were initially infected with PFV-1 (0.1 PFU/ml), and cells that survived acute infection were cultured until disappearance of the cytopathic effect, which occurred after 4 weeks. At that time, remaining lysis-resistant H9 cells (referred to as H9 PFV-1 cells hereafter) harbored the PFV⌬Tas genome, representing a minor fraction of the viral genomes, as reported with other human hematopoietic cell lines (Fig. 1A) (33) . Persistent PFV-1 infection was confirmed by showing that H9 PFV-1 cell virus production was reduced by Ͼ90%, as measured using BHK21 indicator cells expressing the green fluorescent protein (GFP) under the control of PFV-1 long terminal repeats (LTR) (28) (Fig. 1B) . Accordingly, radio-immunoprecipitation of PFV-1 proteins from both the nuclear and cytoplasmic fractions of H9 PFV-1 cells showed that they mainly produced the Bet protein (11) (Fig. 1C) . Because nuclear PFV-1 Gag doublets were also faintly detected in H9 PFV-1 cells, both fractions were analyzed by Western blotting, which allows more accurate detection of this product (Fig. 1D ): indeed, H9
PFV-1 cells still expressed PFV-1 Gag, indicating that they retained the capacity to drive protein expression from the 5Ј LTR.
To investigate the impact of persistent infection by PFV-1 on the early steps of the HIV-1 replication cycle, we examined HIV-1 entry, nuclear import, and integration in H9
PFV-1 cells. The H9
PFV-1 cells were synchronized in G 1 by double-thymidin block (2 mM; Sigma-Aldrich) (6) before a 2-h exposure to X4 HIV-1 NL4-3 (1 g of p24 equivalent/3 ϫ 10 6 cells; NIH AIDS Research and Reference Reagents Program). Virusexposed cells were kept arrested for 24 h at the G 1 /S boundary with 5 g of aphidicolin (Sigma-Aldrich)/ml to preserve nuclear envelope integrity and maintained in the presence of the HIV protease inhibitor Saquinavir (1 g/ml; Roche Pharmaceuticals) to limit analysis to single-round infection. HIV-1 DNA copy numbers detected 6 h p.i. averaged 830 Ϯ 214 and 5,341 Ϯ 2,229 (mean Ϯ SEM; n ϭ 4) per 10 3 parental and H9
PFV-1 cells (sixfold increase), respectively ( Fig.  2A) . Specificity of this phenomenon was controlled by exposing H9
PFV-1 cells to a vesicular stomatitis virus glycoprotein (VSV-G)-pseudotyped NL4-3 virus. Strikingly, PCR analysis 6 h p.i. showed that HIV-1 DNA amounts were 50% lower in H9
PFV-1 cells than in parental cells, indicating that the former had a reduced capacity to support virus entry via endocytosis (Fig. 2B ). There was no difference between parental and H9
PFV-1 cells concerning HIV-1 reverse transcription (reverse transcription efficiency, Ն80%), nuclear import, and integration ( Fig. 2C and D) , indicating that persistent infection by PFV-1 led to increased permissiveness to HIV-1 without affecting major postentry events.
To examine whether persistent infection by PFV-1 also enhanced HIV-1 cell-to-cell transmission, H9
PFV-1 cells were exposed to HIV-1 NL4-3 and cocultured for 24 h with P4-CCR5 indicator cells expressing the ␤-galactosidase gene under HIV-1 LTR control (1). Virus transmission was then two-to sixfold more efficient with H9
PFV-1 cells than with parental cells (Fig. 2E and F) . Because these data suggested that persistent PFV-1 infection enhanced membrane attachment of HIV-1, we next assessed H9
PFV-1 cell-associated p24 two h after exposure to HIV-1 NL4-3 . Cell-associated p24 averaged 480 Ϯ 302 ng/10 6 H9 PFV-1 cells versus 45 Ϯ 20 ng/10 6 H9
PFV-1 cells for parental cells (mean Ϯ standard error of the mean [SEM]; n ϭ 4; 10-fold increase). Spinoculation, which increased the level of cell-associated p24 by 10-to 50-fold relative to simple incubation, did not change the overall pattern, ruling out the effect of centrifugation on virus attachment to H9 PFV-1 cells (Fig. 3A and B) . H9 PFV-1 cell capacity to bind X4 Legrand, CEA, Fontenay aux Roses, France), or the VSV-G pseudotype was then tested (Fig. 3C ). H9 PFV-1 cells displayed 5-to 14-fold-increased capacity to bind the HIV-1 or simian immunodeficiency virus (SIV) strains tested. No difference was noted regarding VSV-G pseudotype binding, which emphasizes the specificity of the phenomenon.
Whether Bet was responsible for increased attachment of HIV-1 to H9 PFV-1 cells was then examined, because Bet plays an important role in the establishment and/or maintenance of PFV-1 persistence (16, 25) . For that purpose, a murine leukemia virus (MLV)-based retrovirus vector (MSCV retroviral (5). Primers sense L-M667 (5Ј-ATGCCACGTAAGCGAAACTCTGGCTAACTAGGGAACCCACTG), antisense Alu-1 (5Ј-TCCCAGCTACTGGGGAGGCTGAGG), and sense Alu-2 (5Ј-GCCTCCCAAAGTGCTGGGATTACAG) were used for the first 12 amplification cycles. Primers sense Lambda-T (5Ј-ATGCCACGTAAGCGAAACT) and antisense AASSM (5Ј-GCTAGAGATTTTCCACACTGAC TAA, nucleotides 609 to 633) were used for the second-round PCR. Detection of the corresponding amplicons was achieved with hybridization probes, and standard curves for integrated viral DNA were generated by using HeLa cells infected with a ⌬env HIV-1 R7 Neo virus. Integrated proviral DNA copy numbers were normalized relative to 10 4 copies of full-length HIV-1 DNA. (E and F) Cell-to-cell transmission of HIV-1 by H9
PFV-1 cells: H9 PFV-1 and parental cells were spinoculated at 4°C for 2 h in the presence of HIV-1 NL4-3 (0.01 to 1 g of p24 equivalent/3 ϫ 10 6 cells) before they were added for 24 h to P4-CCR5 indicator cells that express the ␤-galactosidase reporter gene under the control of HIV-1 LTR (23). P4-CCR5 cells were fixed and processed for 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside staining 48 h later (E). Results are expressed as mean numbers (plus SEM) of blue cells per field (F); 30 fields were counted for each condition; they are representative of one experiment out of two.
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NOTESexpression system; Clontech) was used to stably transduce Bet into H9 cells (Fig. 4A) . After exposure to HIV-1 NL4-3 of two clones selected for high levels of Bet expression, no difference was noted regarding virus binding, entry, or replication ( PFV-1 cells (Fig. 4C) . Because surface polyanions and glycans also contribute to HIV-1 attachment to target cells (20, 21, 27) , the effect of heparin, mannan, and dextran 10000 (all from Sigma-Aldrich) on binding of HIV-1 NL4-3 to cells was assessed: 1-h preincubation of H9
PFV-1 cells with heparin inhibited HIV-1-enhanced cell association in a dosedependent manner, while neither mannan nor dextran had such an effect ( Fig. 4D and E and data not shown) . Thus, change of surface expression of heparan-sulfate proteoglycans could be responsible for increased capacity of H9 PFV-1 cells to bind HIV-1 (2).
These results demonstrate that H9 cells persistently infected with PFV-1 display an increased capacity to capture HIV-1 via interactions with heparan-sulfate proteoglycans, whose ability to attach HIV-1 gp120 is well documented (24) . The phenomenon is independent of PFV-1 Bet, suggesting that other viral proteins modulate expression of membrane proteoglycans. This hypothesis is supported by the lack of PFV-1 LTR complete silencing in H9
PFV-1 cells. Although our findings cannot be extrapolated to in vivo-coinfected nonhuman primates, they nonetheless provide the first evidence of interactions between FVs and lentiviruses. Because PFVs replicate in mucosae of infected individuals (3, 8) and can be isolated from blood T cells (29) , one should consider the hypothesis that PVFinfected cells may be involved in the natural history of SIV infection. We gratefully thank Micael Bukrinsky for the gift of the pNLHX HIV-1 strain; Robert Siliciano for the gift of pNL4-3 GFP reporter virus; Roger Legrand and Bruno Vaslin for the gift of SIVmac251 and critical discussions; and the National Institutes of Health AIDS Research and Reference Reagents Program for the gift of the pNL4-3 molecular clone and the pVSV-G expression vector.
